Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Parkinson's Disease

  Free Subscription

Articles published in Neurosci Lett

Retrieve available abstracts of 94 articles:
HTML format

Single Articles

    November 2022
  1. CHEN Y, Li Y, Li C, Zhu D, et al
    Dexmedetomidine alleviates pain in MPTP-treated mice by activating the AMPK/mTOR/NF-kappaB pathways in astrocytes.
    Neurosci Lett. 2022;791:136933.
    PubMed     Abstract available

  2. HU ZX, Pu JL, Zheng R, Yan YQ, et al
    Mitochondrial morphology and synaptic structure altered in the retina of parkin-deficient mice.
    Neurosci Lett. 2022;790:136888.
    PubMed     Abstract available

    October 2022
  3. ZHANG X, Wang S, Li X, Li X, et al
    Hemoglobin-binding alpha-synuclein levels in erythrocytes are elevated in patients with multiple system atrophy.
    Neurosci Lett. 2022;789:136868.
    PubMed     Abstract available

  4. YU Z, Huang L, Xia Y, Cheng S, et al
    Analysis of the m6A modification regulators in the substantia nigra and striatum of MPTP-induced Parkinson's disease mice.
    Neurosci Lett. 2022 Oct 6:136907. doi: 10.1016/j.neulet.2022.136907.
    PubMed     Abstract available

    September 2022
  5. LIU X, Qi Y, Zhao G, Zhang Z, et al
    Expression profiles of microRNAs in midbrain of MPTP-treated mice determined by microRNA sequencing.
    Neurosci Lett. 2022;788:136841.
    PubMed     Abstract available

  6. SADEGHIAN Z, Eyvari Brooshghalan S, Sabahi M, Nourouzi N, et al
    Post treatment with Gastrodin suppresses oxidative stress and attenuates motor disorders following 6-OHDA induced Parkinson disease.
    Neurosci Lett. 2022 Sep 23:136884. doi: 10.1016/j.neulet.2022.136884.
    PubMed     Abstract available

  7. LIU Q, Jiang B, Zou M, Wan HJ, et al
    A genetic analysis of Chinese patients with early-onset Parkinson' s disease.
    Neurosci Lett. 2022 Sep 20:136880. doi: 10.1016/j.neulet.2022.136880.
    PubMed     Abstract available

    August 2022
  8. BERG A, Bech S, Aasly J, Farrer MJ, et al
    Autonomic dysfunction in Parkinson's disease: Results from the Faroese Parkinson's disease cohort.
    Neurosci Lett. 2022;785:136789.
    PubMed     Abstract available

  9. ZHENG JH, Sun WH, Ma JJ, Wang ZD, et al
    Structural and functional abnormalities in Parkinson's disease based on voxel-based morphometry and resting-state functional magnetic resonance imaging.
    Neurosci Lett. 2022;788:136835.
    PubMed     Abstract available

    July 2022
  10. CHATTERJEE K, Choudhury S, Banerjee R, Siddique U, et al
    Is peripheral alpha synuclein a marker for gait velocity in Parkinson's disease?
    Neurosci Lett. 2022;786:136819.
    PubMed     Abstract available

  11. XU X, Li Z, Zuo H, Chen H, et al
    Mesenchymal stem cell-derived exosomes altered neuron cholesterol metabolism via Wnt5a-LRP1 axis and alleviated cognitive impairment in a progressive Parkinson's disease model.
    Neurosci Lett. 2022 Jul 20:136810. doi: 10.1016/j.neulet.2022.136810.
    PubMed     Abstract available

  12. EL AISSOUQ A, Bouachrine M, Ouammou A, Khalil F, et al
    Homology modeling, virtual screening, molecular docking, molecular dynamic (MD) simulation, and ADMET approaches for identification of natural anti-Parkinson agents targeting MAO-B protein.
    Neurosci Lett. 2022 Jul 13:136803. doi: 10.1016/j.neulet.2022.136803.
    PubMed     Abstract available

    June 2022
  13. ROY A, Banerjee R, Choudhury S, Chatterjee K, et al
    Novel Inflammasome and Oxidative Modulators in Parkinson's Disease: A Prospective Study.
    Neurosci Lett. 2022 Jun 30:136768. doi: 10.1016/j.neulet.2022.136768.
    PubMed     Abstract available

  14. RAN C, Brodin L, Gellhaar S, Westerlund M, et al
    Glucocerebrosidase variant T369M is not a risk factor for Parkinson's disease in Sweden.
    Neurosci Lett. 2022;784:136767.
    PubMed     Abstract available

  15. XU B, Wang X, Xu Z, Li Q, et al
    N-cystaminylbiguanide MC001 prevents neuron cell death and alleviates motor deficits in the MPTP-model of Parkinson's disease.
    Neurosci Lett. 2022 Jun 20:136751. doi: 10.1016/j.neulet.2022.136751.
    PubMed     Abstract available

  16. LI C, Hou B, Li X, Yang Z, et al
    Role of CD36 rs1761667 AA genotype in the expression of inflammatory cytokines and Parkinson's disease progression: A case-control study in a northern Han Chinese population.
    Neurosci Lett. 2022;784:136736.
    PubMed     Abstract available

  17. SHI X, Zheng J, Ma J, Wang Z, et al
    Insulin-like growth factor in Parkinson's disease is related to nonmotor symptoms and the volume of specific brain areas.
    Neurosci Lett. 2022;783:136735.
    PubMed     Abstract available

  18. YANG Z, Xue L, Li C, Li M, et al
    Association between ABCA7 gene polymorphisms and Parkinson's disease susceptibility in a northern Chinese Han population.
    Neurosci Lett. 2022;784:136734.
    PubMed     Abstract available

    May 2022
  19. WANG LX, Liu C, Shao YQ, Jin H, et al
    Peripheral Blood Inflammatory Cytokines are Associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson's Disease.
    Neurosci Lett. 2022 May 20:136692. doi: 10.1016/j.neulet.2022.136692.
    PubMed     Abstract available

  20. SHKODINA AD, Tarianyk KA, Boiko DI, Zehravi M, et al
    Cognitive and affective disturbances in patients with Parkinson's disease: perspectives for classifying of motor/neuropsychiatric subtypes.
    Neurosci Lett. 2022 May 6:136675. doi: 10.1016/j.neulet.2022.136675.
    PubMed     Abstract available

    April 2022
  21. ZHANG J, Wang M, Zhao Y, Zhang Y, et al
    Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord.
    Neurosci Lett. 2022;781:136669.
    PubMed     Abstract available

  22. LIM HS, Park G
    Resilin, an insect-derived elastomeric protein, protects dopaminergic neurons in Parkinson disease models.
    Neurosci Lett. 2022;781:136667.
    PubMed     Abstract available

  23. CHEN W, Hou C, Wang Y, Hong L, et al
    Circular RNA circTLK1 regulates dopaminergic neuron injury during Parkinson's disease by targeting miR-26a-5pDAPK1.
    Neurosci Lett. 2022 Apr 18:136638. doi: 10.1016/j.neulet.2022.136638.
    PubMed     Abstract available

    March 2022
  24. WANG Y, Luan M, Xue L, Jin J, et al
    Evaluation of the relationship between SORL1 gene polymorphism and Parkinson's disease in the Chinese population.
    Neurosci Lett. 2022;778:136602.
    PubMed     Abstract available

  25. NING P, Li K, Ren H, Yang H, et al
    Rare missense variants in the PPP2R5D gene associated with Parkinson's disease in the Han Chinese population.
    Neurosci Lett. 2022;776:136564.
    PubMed     Abstract available

    February 2022
  26. LUAN M, Jin J, Wang Y, Li X, et al
    Association of PGLYRP2 gene polymorphism and sporadic Parkinson's disease in northern Chinese Han population.
    Neurosci Lett. 2022;775:136547.
    PubMed     Abstract available

  27. COSTA TM, Simieli L, Bersotti FM, Mochizuki L, et al
    Gait and posture are correlated domains in Parkinson's disease.
    Neurosci Lett. 2022 Feb 19:136537. doi: 10.1016/j.neulet.2022.136537.
    PubMed     Abstract available

  28. NICHOLATOS JW, Tran D, Liu Y, Hirst WD, et al
    Lysophosphatidylcholine acyltransferase 1 promotes pathology and toxicity in two distinct cell-based alpha-synuclein models.
    Neurosci Lett. 2022;772:136491.
    PubMed     Abstract available

  29. WANG XL, Feng ST, Chen B, Hu D, et al
    Efficacy and safety of istradefylline for Parkinson's disease: A systematic review and meta-analysis.
    Neurosci Lett. 2022;774:136515.
    PubMed     Abstract available

    January 2022
  30. VIREL A, Johansson J, Axelsson J, Ericsson M, et al
    N-acetylcysteine decreases dopamine transporter availability in the non-lesioned striatum of the 6-OHDA hemiparkinsonian rat.
    Neurosci Lett. 2022;770:136420.
    PubMed     Abstract available

  31. ZHAO Y, Qi Y, Li Q, Quan H, et al
    Connexin43 inhibition attenuated dopaminergic neuronal loss in the lipopolysaccharide-induced mice model of Parkinson's disease.
    Neurosci Lett. 2022;771:136471.
    PubMed     Abstract available

  32. VITORINO LC, Oliveira KF, da Silva WAB, de Andrade Gomes CAB, et al
    Physical exercise influences astrocytes in the striatum of a Parkinson's disease male mouse model.
    Neurosci Lett. 2022;771:136466.
    PubMed     Abstract available

  33. AFSHARI D, Shakeri J, Khodamoradi M, Nejad Shahrokh Abadi R, et al
    Efficacy of electroconvulsive therapy in Parkinson's disease: a clinical trial.
    Neurosci Lett. 2022 Jan 10:136449. doi: 10.1016/j.neulet.2022.136449.
    PubMed     Abstract available

    December 2021
  34. OSTRAKHOVITCH EA, Song ES, Macedo JKA, Gentry MS, et al
    Analysis of circulating metabolites to differentiate Parkinson's disease and essential tremor.
    Neurosci Lett. 2021;769:136428.
    PubMed     Abstract available

  35. SANG T, He J, Wang J, Zhang C, et al
    Alterations in white matter fiber in Parkinson's disease across different cognitive stages.
    Neurosci Lett. 2021 Dec 24:136424. doi: 10.1016/j.neulet.2021.136424.

  36. LI Y, Li Z, Gu J, Xu X, et al
    Exosomes isolated during dopaminergic neuron differentiation suppressed neuronal inflammation in a rodent model of Parkinson's disease.
    Neurosci Lett. 2021;771:136414.
    PubMed     Abstract available

  37. PARK DG, Kang J, An YS, Chang J, et al
    Association of plasma alpha-synuclein with cardiac (123)I-MIBG scintigraphy in early Parkinson's disease.
    Neurosci Lett. 2021;770:136399.
    PubMed     Abstract available

    November 2021
  38. LI B, Yang S, Ye J, Chu S, et al
    Flavin-containing monooxygenase 1 deficiency promotes neuroinflammation in dopaminergic neurons in mice.
    Neurosci Lett. 2021;764:136222.
    PubMed     Abstract available

    October 2021
  39. PENGV B, Gong Z, Zhang Y, Shen B, et al
    Self-paced learning and privileged information Based KRR classification algorithm for diagnosis of Parkinson's disease.
    Neurosci Lett. 2021 Oct 29:136312. doi: 10.1016/j.neulet.2021.136312.
    PubMed     Abstract available

  40. BIAN K, Liu C, Wang Y, Xue Y, et al
    Orexin-B exerts excitatory effects on nigral dopaminergic neurons and alleviates motor disorders in MPTP parkinsonian mice.
    Neurosci Lett. 2021;765:136291.
    PubMed     Abstract available

  41. PANDI S, Chinniah R, Sevak V, Ravi PM, et al
    Association of HLA-DRB1, DQA1 and DQB1 alleles and haplotype in Parkinson's disease from South India.
    Neurosci Lett. 2021;765:136296.
    PubMed     Abstract available

    September 2021
  42. IKUNO M, Yamakado H, Amano I, Hatanaka Y, et al
    Mitochondrial Dysfunction in a Mouse Model of Prodromal Parkinson's Disease: A Metabolomic Analysis.
    Neurosci Lett. 2021 Sep 24:136267. doi: 10.1016/j.neulet.2021.136267.
    PubMed     Abstract available

  43. JIN JUNG Y, Choi H, Oh E
    Effects of particulate matter and nicotine for the MPP+-induced SH-SY5Y cells: Implication for Parkinson's disease.
    Neurosci Lett. 2021 Sep 23:136265. doi: 10.1016/j.neulet.2021.136265.

  44. POTTENGER AE, Bartlett MJ, Sherman SJ, Falk T, et al
    Evaluation of microglia in a rodent model of Parkinson's disease primed with L-DOPA after sub-anesthetic ketamine treatment.
    Neurosci Lett. 2021 Sep 15:136251. doi: 10.1016/j.neulet.2021.136251.
    PubMed     Abstract available

  45. PAULETTI C, Mannarelli D, Locuratolo N, Maffucci A, et al
    Serotonergic central tone in Parkinson's disease with fatigue: evidence from the loudness dependence of auditory evoked potentials (LDAEP).
    Neurosci Lett. 2021 Sep 9:136242. doi: 10.1016/j.neulet.2021.136242.
    PubMed     Abstract available

  46. CHUNG J, Ushakova A, Doitsidou M, Tzoulis C, et al
    The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: a longitudinal observational study.
    Neurosci Lett. 2021 Sep 9:136243. doi: 10.1016/j.neulet.2021.136243.
    PubMed     Abstract available

    August 2021
  47. MURATA T, Tochio N, Utsunomiya-Tate N
    Physicochemical characterization of the G51D mutation of alpha-synuclein that is responsible for its severe cytotoxicity.
    Neurosci Lett. 2021;760:136077.
    PubMed     Abstract available

  48. LIU Y, Huang Q, Wei Z, Ma S, et al
    GSK-3 mediates nuclear translocation of p62/SQSTM1 in MPTP-induced mouse model of Parkinson's disease.
    Neurosci Lett. 2021 Aug 13:136177. doi: 10.1016/j.neulet.2021.136177.
    PubMed     Abstract available

  49. TU HY, Gu YQ, Li X, Pei SF, et al
    Expression of autophagy related genes in peripheral blood cells in Parkinson's disease.
    Neurosci Lett. 2021 Aug 6:136166. doi: 10.1016/j.neulet.2021.136166.
    PubMed     Abstract available

  50. ZHENG R, Qiao S, Chen Y, Jin C, et al
    Association analysis and polygenic risk score evaluation of 38 GWAS-identified Loci in a Chinese population with Parkinson's disease.
    Neurosci Lett. 2021;762:136150.
    PubMed     Abstract available

  51. TANG C, Zhao X, Wu W, Zhong W, et al
    An individualized prediction of time to cognitive impairment in Parkinson's disease: a combined multi-predictor study.
    Neurosci Lett. 2021 Aug 2:136149. doi: 10.1016/j.neulet.2021.136149.
    PubMed     Abstract available

    July 2021
  52. SALJUQI M, Ghaderyan P
    A novel method based on matching pursuit decomposition of gait signals for Parkinson's disease, Amyotrophic lateral sclerosis and Huntington's disease detection.
    Neurosci Lett. 2021 Jul 10:136107. doi: 10.1016/j.neulet.2021.136107.
    PubMed     Abstract available

    June 2021
  53. BAI X, Dong Q, Zhao L, Yao Y, et al
    microRNA-106b-containing extracellular vesicles affect autophagy of neurons by regulating CDKN2B in Parkinson's disease.
    Neurosci Lett. 2021 Jun 30:136094. doi: 10.1016/j.neulet.2021.136094.
    PubMed     Abstract available

  54. DA SILVA WAB, Ferreira Oliveira K, Caroline Vitorino L, Ferreira Romao L, et al
    Physical exercise increases the production of tyrosine hydroxylase and CDNF in the spinal cord of a Parkinson's disease mouse model.
    Neurosci Lett. 2021 Jun 25:136089. doi: 10.1016/j.neulet.2021.136089.
    PubMed     Abstract available

  55. SUN D, Wu X, Xia Y, Wu F, et al
    Differentiating Parkinson's Disease Motor Subtypes: A Radiomics Analysis Based on Deep Gray Nuclear Lesion and White Matter.
    Neurosci Lett. 2021 Jun 23:136083. doi: 10.1016/j.neulet.2021.136083.
    PubMed     Abstract available

  56. YIN K, Zhou C, Yin L, Zhu Y, et al
    Resting-state functional magnetic resonance imaging of the cerebellar vermis in patients with Parkinson's disease and visuospatial disorder.
    Neurosci Lett. 2021;760:136082.
    PubMed     Abstract available

  57. XU X, He X, Ma S, Li M, et al
    Nurr1 downregulation is caused by CREB inactivation in a Parkinson's disease mouse model.
    Neurosci Lett. 2021;759:136045.
    PubMed     Abstract available

  58. NIYOMRAT K, Cheaha D, Nukitram J, Kumarnsit E, et al
    Locomotor activity and resting local field potential oscillatory rhythms of 6-OHDA mouse model of Parkinson's disease in response to acute and repeated treatments with L-dopa.
    Neurosci Lett. 2021 Jun 4:136007. doi: 10.1016/j.neulet.2021.136007.
    PubMed     Abstract available

    May 2021
  59. LI N, Suo X, Zhang J, Lei D, et al
    Disrupted functional brain network topology in Parkinson's disease patients with freezing of gait.
    Neurosci Lett. 2021 May 20:135970. doi: 10.1016/j.neulet.2021.135970.
    PubMed     Abstract available

  60. TAKAHASHI K, Iwaoka K, Takahashi K, Suzuki Y, et al
    Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson's disease and progressive supranuclear palsy.
    Neurosci Lett. 2021 May 20:135975. doi: 10.1016/j.neulet.2021.135975.
    PubMed     Abstract available

  61. RONG Z, Shen F, Wang Y, Sun L, et al
    Phosphorylated alpha-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
    Neurosci Lett. 2021;756:135964.
    PubMed     Abstract available

    April 2021
  62. VENKATESAN D, Iyer M, S RW, G L, et al
    The association between multiple risk factors, clinical correlations and molecular insights in Parkinson's disease patients from Tamil Nadu population, India.
    Neurosci Lett. 2021;755:135903.
    PubMed     Abstract available

  63. SALAS-LEAL AC, Salas-Pacheco SM, Gavilan-Ceniceros JAP, Castellanos-Juarez FX, et al
    alpha-syn and SNP rs356219 as a potential biomarker in blood for Parkinson's disease in Mexican Mestizos.
    Neurosci Lett. 2021;754:135901.
    PubMed     Abstract available

  64. ZHANG L, He Y, Lei K, Fang Z, et al
    Gene expression profiling of early Parkinson's disease patient reveals redox homeostasis.
    Neurosci Lett. 2021;753:135893.
    PubMed     Abstract available

  65. BAI X, Liu X, Li X, Li W, et al
    Association between VPS13C rs2414739 polymorphism and Parkinson's disease risk: A meta-analysis.
    Neurosci Lett. 2021 Apr 7:135879. doi: 10.1016/j.neulet.2021.135879.
    PubMed     Abstract available

  66. RAJ K, Kaur P, Gupta GD, Singh S, et al
    Metals associated neurodegeneration in Parkinson's disease: Insight to physiological, pathological mechanisms and management.
    Neurosci Lett. 2021;753:135873.
    PubMed     Abstract available

  67. KAKOTY V, K C S, Dubey SK, Yang CH, et al
    The gut-brain connection in the pathogenicity of Parkinson disease: Putative role of autophagy.
    Neurosci Lett. 2021;753:135865.
    PubMed     Abstract available

  68. WERNICK AI, Walton RL, Soto-Beasley AI, Koga S, et al
    Investigating ELOVL7 coding variants in multiple system atrophy.
    Neurosci Lett. 2021;749:135723.
    PubMed     Abstract available

    March 2021
  69. NAUSHAD SM, Hussain T, Alrokayan S, Kutala VK, et al
    Alpha synuclein (SNCA) rs7684318 variant contributes to Parkinson's disease risk by altering transcription factor binding related with Notch and Wnt signaling.
    Neurosci Lett. 2021 Mar 8:135802. doi: 10.1016/j.neulet.2021.135802.
    PubMed     Abstract available

    February 2021
  70. KAKOTY V, Sarathlal KC, Dubey SK, Yang CH, et al
    Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease.
    Neurosci Lett. 2021 Feb 23:135769. doi: 10.1016/j.neulet.2021.135769.
    PubMed     Abstract available

  71. SHARMA T, Kaur D, Grewal AK, Singh TG, et al
    Therapies modulating insulin resistance in Parkinson's disease: A cross talk.
    Neurosci Lett. 2021 Feb 18:135754. doi: 10.1016/j.neulet.2021.135754.
    PubMed     Abstract available

  72. SIOKAS V, Arseniou S, Aloizou AM, Tsouris Z, et al
    CD33 rs3865444 as a risk factor for Parkinson's disease.
    Neurosci Lett. 2021 Feb 11:135709. doi: 10.1016/j.neulet.2021.135709.
    PubMed     Abstract available

    January 2021
  73. GUO W, Jin W, Li N, Gao J, et al
    Brain activity alterations in patients with Parkinson's disease with cognitive impairment based on resting-state functional MRI.
    Neurosci Lett. 2021 Jan 27:135672. doi: 10.1016/j.neulet.2021.135672.
    PubMed     Abstract available

  74. LEE SH, Han YT, Cha DS
    Neuroprotective effect of damaurone D in a C. elegans model of Parkinson's Disease.
    Neurosci Lett. 2021 Jan 19:135623. doi: 10.1016/j.neulet.2021.135623.
    PubMed     Abstract available

  75. ZHANG L, Yang H
    Promotive effects of tetrahydroxystilbene glucoside on the differentiation of neural stem cells from the mesencephalon into dopaminergic neurons.
    Neurosci Lett. 2021;742:135520.
    PubMed     Abstract available

  76. DONG MX, Hu L, Wei YD, Chen GH, et al
    Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.
    Neurosci Lett. 2021 Jan 10:135626. doi: 10.1016/j.neulet.2021.135626.
    PubMed     Abstract available

  77. TAGHIZADEH G, Joghataei MT, Goudarzi S, Bakhsheshi M, et al
    King's Parkinson's disease Pain Scale Cut-off Points for Detection of Pain Severity Levels: A Reliability and Validity Study.
    Neurosci Lett. 2021 Jan 8:135620. doi: 10.1016/j.neulet.2020.135620.
    PubMed     Abstract available

    December 2020
  78. YU LH, Peng GP, Yuan Y, Liu XY, et al
    Novel compound heterozygous of PARKIN causes early-onset Parkinson's disease.
    Neurosci Lett. 2020;744:135597.
    PubMed     Abstract available

    November 2020
  79. FLORES-SOTO ME, Corona-Angeles JA, Tejeda-Martinez AR, Flores-Guzman PA, et al
    Neurosci Lett. 2020 Nov 30:135534. doi: 10.1016/j.neulet.2020.135534.
    PubMed     Abstract available

  80. USENKO TS, Bezrukova AI, Bogdanova DA, Kopytova AE, et al
    Genetics variants and expression of the SCARB2 gene in the pathogenesis of Parkinson's disease in Russia.
    Neurosci Lett. 2020 Nov 20:135509. doi: 10.1016/j.neulet.2020.135509.
    PubMed     Abstract available

  81. WANG S, Zhang Y, Lei J, Guo S, et al
    Investigation of Sensorimotor Dysfunction in Parkinson Disease by Resting-state fMRI.
    Neurosci Lett. 2020 Nov 19:135512. doi: 10.1016/j.neulet.2020.135512.
    PubMed     Abstract available

  82. LI MG, Bian XB, Zhang J, Wang ZF, et al
    Aberrant Voxel-based Degree Centrality in Parkinson's Disease Patients with Mild Cognitive Impairment.
    Neurosci Lett. 2020 Nov 17:135507. doi: 10.1016/j.neulet.2020.135507.
    PubMed     Abstract available

  83. QI H, Shen D, Jiang C, Wang H, et al
    Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP/MPP(+)-induced Parkinson's disease.
    Neurosci Lett. 2020 Nov 9:135493. doi: 10.1016/j.neulet.2020.135493.
    PubMed     Abstract available

  84. LIU Z, Ye Q, Wang F, Guo Y, et al
    Protective effect of thioredoxin reductase 1 in Parkinson's disease.
    Neurosci Lett. 2020 Nov 7:135457. doi: 10.1016/j.neulet.2020.135457.
    PubMed     Abstract available

  85. BALTUS THL, Morelli NR, de Farias CC, Trugilo KP, et al
    Association of -94 ATTG insertion/deletion NFkB1 and c.*126G>A NFkBIA genetic polymorphisms with oxidative and nitrosative stress biomarkers in Brazilian subjects with Parkinson's Disease.
    Neurosci Lett. 2020;740:135487.
    PubMed     Abstract available

  86. HUANG S, Zhao Z, Ma J, Hu S, et al
    Increased plasma orexin-A concentrations are associated with the Non-motor symptoms in Parkinson's disease patients.
    Neurosci Lett. 2020 Nov 5:135480. doi: 10.1016/j.neulet.2020.135480.
    PubMed     Abstract available

  87. YANG Q, Nanivadekar S, Taylor PA, Dou Z, et al
    Executive function network's white matter alterations relate to Parkinson's disease motor phenotype.
    Neurosci Lett. 2020 Nov 5:135486. doi: 10.1016/j.neulet.2020.135486.
    PubMed     Abstract available

    October 2020
  88. SAHAI S, Effendi ET, Mahoney EC, Tucker HR, et al
    Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson's disease.
    Neurosci Lett. 2020;739:135443.
    PubMed     Abstract available

  89. SONG MK, Lee JH, Kim J, Kim JH, et al
    Neuroprotective effect of NXP031 in the MPTP-induced Parkinson's disease model.
    Neurosci Lett. 2020 Oct 16:135425. doi: 10.1016/j.neulet.2020.135425.
    PubMed     Abstract available

  90. KESH S, Kannan RR, Sivaji K, Balakrishnan A, et al
    Hesperidin downregulates kinases lrrk2 and gsk3beta in a 6-OHDA induced Parkinson's disease model.
    Neurosci Lett. 2020 Oct 16:135426. doi: 10.1016/j.neulet.2020.135426.
    PubMed     Abstract available

    September 2020
  91. SUBRAMANIAN N, Ramanathan S, Venkatesan V, Koshy T, et al
    A Case-Control Association of RANTES (-28C >G) and CCR5-Delta32 Polymorphisms with Parkinson's Disease in Indians.
    Neurosci Lett. 2020 Sep 25:135404. doi: 10.1016/j.neulet.2020.135404.
    PubMed     Abstract available

    April 2020
  92. LENG B, Sun H, Zhao J, Liu Y, et al
    Plasma exosomal prion protein levels are correlated with cognitive decline in PD patients.
    Neurosci Lett. 2020;723:134866.
    PubMed     Abstract available

    February 2020
  93. FURLONG RM, O'Keeffe GW, O'Neill C, Sullivan AM, et al
    Alterations in alpha-synuclein and PINK1 expression reduce neurite length and induce mitochondrial fission and Golgi fragmentation in midbrain neurons.
    Neurosci Lett. 2020;720:134777.
    PubMed     Abstract available

    January 2020
  94. SANNA A, Follesa P, Puligheddu M, Cannas A, et al
    Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels.
    Neurosci Lett. 2020;716:134653.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.